Subscribe
shutterstock_587302397_pirke
pirke / Shutterstock.com
23 April 2019Medtech

Neovasc adds two co-inventors to heart valve patents

Medical device company  Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor,  Edwards Lifesciences.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Federal Circuit denies CardiAQ injunction request against Neovasc
5 September 2017   The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
Federal Circuit denies CardiAQ injunction request against Neovasc
5 September 2017   The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

More on this story

Americas
Federal Circuit denies CardiAQ injunction request against Neovasc
5 September 2017   The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner